antiviral Archives - Page 4 of 5 -

Merck & Co is on the brink of plugging a gap in the coronavirus treatment armamentarium after its

Merck preps filings for oral COVID drug, but is it really a game changer?

https://pharmaphorum.com/news/merck-preps-filings-for-oral-covid-drug-but-is-it-really-a-game-changer/

Digital/ News/ News

Gates Foundation ramps up funding to Exscientia in COVID project

Phil Taylor antiviral, Bill and Melinda Gates Foundation, coronavirus, COVID-19, exscientia, financing 0 Comment

The Bill & Melinda Gates Foundation must have liked what it saw in an initial collaboration with Exscientia

Gates Foundation ramps up funding to Exscientia in COVID project

https://pharmaphorum.com/news/gates-foundation-ramps-up-funding-to-exscientia-in-covid-project/

Market Access/ News/ News

Merck kicks off oral COVID-19 antiviral filing in Canada

Phil Taylor antiviral, Canada, coronavirus, COVID-19, Merck & Co, molnupiravir 0 Comment

Health Canada has started a rolling review of Merck & Co’s molnupiravir, an oral antiviral therapy treatment for

Merck kicks off oral COVID-19 antiviral filing in Canada

https://pharmaphorum.com/news/merck-kicks-off-oral-covid-19-antiviral-filing-in-canada/

News/ News/ R&D

White House pledges $3 billion war chest for COVID antivirals

Phil Taylor antiviral, coronavirus, COVID-19, Funding, Joe Biden, US 0 Comment

The Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development

White House pledges $3 billion war chest for COVID antivirals

https://pharmaphorum.com/news/white-house-pledges-3-billion-war-chest-for-covid-antivirals/

News/ News/ Sales and Marketing

Merck nabs $1.2 billion order for oral COVID antiviral from US

Phil Taylor antiviral, coronavirus, COVID-19, Merck & Co, molnupiravir, US 0 Comment

The US government has placed an order with Merck & Co to buy 1.7 million courses of its

Merck nabs $1.2 billion order for oral COVID antiviral from US

https://pharmaphorum.com/news/merck-grabs-1-2-billion-order-for-oral-covid-antiviral-from-us/

Nebuliser being filled. Copyright Vectura (002)

News/ News/ R&D

New UK biotech Inspira uncloaks with deal to develop inhaled COVID therapy

Phil Taylor antiviral, Biotech, coronavirus, COVID-19, Inspira Pharmaceuticals, UK 0 Comment

UK biotech Inspira Pharmaceuticals has emerged from stealth mode with a deal with Vectura to develop an inhaled

New UK biotech Inspira uncloaks with deal to develop inhaled COVID therapy

https://pharmaphorum.com/news/new-uk-biotech-inspira-uncloaks-with-deal-to-develop-inhaled-covid-therapy/

Market Access/ News/ News

ViiV’s Rukobia cleared in EU as rescue HIV therapy

Phil Taylor antiviral, GlaxoSmithKline, HIV, infectious disease, ViiV Healthcare 0 Comment

The European Commission has given a green light to the use of ViiV Healthcare’s Rukobia as a treatment

ViiV’s Rukobia cleared in EU as rescue HIV therapy

https://pharmaphorum.com/news/viivs-rukobia-cleared-in-eu-as-rescue-hiv-therapy/

News/ News/ R&D

BioSig abandons COVID-19 drug trial on safety concerns

Phil Taylor antiviral, BioSig Technologies, coronavirus, COVID-19, Gilead Sciences, Veklury 0 Comment

US biotech BioSig Technologies has abandoned a phase 2 trial of its antiviral drug merimepodib with Gilead’s Veklury

BioSig abandons COVID-19 drug trial on safety concerns

https://pharmaphorum.com/news/biosig-abandons-covid-19-drug-trial-on-safety-concerns/

News/ News/ R&D/ Top stories

Gilead starts trials of inhaled remdesivir for earlier-stage COVID-19

Phil Taylor antiviral, coronavirus, COVID-19, Gilead Sciences, infectious disease, Inhalation, remdesivir 0 Comment

The first healthy volunteers have started to receive doses of Gilead’s inhaled formulation of remdesivir, which it hopes

Gilead starts trials of inhaled remdesivir for earlier-stage COVID-19

https://pharmaphorum.com/news/gilead-starts-trials-of-inhaled-remdesivir-for-earlier-stage-covid-19/

Trending

antiviral

Login